News & Updates

ARBs protect kidney function in hypertensive patients

15 Aug 2022

A recent study using real-world data has found that antihypertensive therapy with angiotensin II receptor blockers (ARBs) can be initiated for kidney protection even in a primary care setting.

ARBs protect kidney function in hypertensive patients

15 Aug 2022

Subgroup analyses boost masupirdine potential for AD

15 Aug 2022 by

Post hoc data from a phase II study presented at AAIC 2022 continue to demonstrate the potential of masupirdine (SUVN-502), a selective 5-HT6 receptor antagonist, as a treatment alternative for the management of neuropsychiatric and cognitive symptoms of Alzheimer’s disease (AD).

Subgroup analyses boost masupirdine potential for AD

15 Aug 2022

Mammography screening tied to better breast cancer characteristics, outcomes

15 Aug 2022 by

Regularly attending mammography screening sessions may lead to better breast cancer (BC) characteristics and help improve overall survival (OS), reports a recent Singapore study.

Mammography screening tied to better breast cancer characteristics, outcomes

15 Aug 2022

Elderly men with PTSD at risk of Parkinson’s

15 Aug 2022

A diagnosis of post-traumatic stress disorder (PTSD) appears to carry an increased risk of developing subsequent Parkinson’s disease among elderly men, as reported in a study.

Elderly men with PTSD at risk of Parkinson’s

15 Aug 2022

Rose Bengal PDAT a promising adjunct therapy for infectious keratitis

15 Aug 2022

In patients with infectious keratitis, Rose Bengal (RB) photodynamic antimicrobial therapy (PDAT) mitigates the need for therapeutic penetrating keratoplasty, as shown in a recent study. However, keratoplasty after RB-PDAT may increase the chances of graft survival at 1 year postoperatively.

Rose Bengal PDAT a promising adjunct therapy for infectious keratitis

15 Aug 2022

Original New Drug Application Approvals by US FDA (01 - 15 August 2022)

15 Aug 2022

New drug applications approved by US FDA as of 01 - 15 August 2022 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Original New Drug Application Approvals by US FDA (01 - 15 August 2022)

15 Aug 2022

Soticlestat shows promise in rare, severe forms of childhood epilepsy

14 Aug 2022

The investigational drug soticlestat (TAK-935) helps reduce seizure frequency in children with Dravet syndrome (DS) or Lennox–Gastaut syndrome (LGS), with its safety profile consistent with previous data, according to the results of the phase II ELEKTRA trial.

Soticlestat shows promise in rare, severe forms of childhood epilepsy

14 Aug 2022

Laparoscopic pancreaticoduodenectomy a feasible oncological intervention

14 Aug 2022

Laparoscopic pancreaticoduodenectomy (LPD) is associated with high rates of early morbidity, reoperation, and transition to laparotomy, reports a recent study. Nevertheless, LPD remains a viable alternative to open pancreaticoduodenectomy (OPD).

Laparoscopic pancreaticoduodenectomy a feasible oncological intervention

14 Aug 2022

HCV reinfection highest among people with ongoing injecting drug use

14 Aug 2022

Reinfection with hepatitis C virus (HCV) is low among people receiving opioid agonist therapy (OAT) but appears to be at its peak during the first 24 weeks following treatment completion and among those with ongoing injecting drug use and needle‒syringe sharing, a study has found.

HCV reinfection highest among people with ongoing injecting drug use

14 Aug 2022

Inverse salt sensitivity predicts CV damage in essential hypertension

14 Aug 2022

Individuals with either salt sensitivity (SS) or inverse salt sensitivity (ISS) appear to be at greater risk of cardiovascular (CV) events, reveals a study.

Inverse salt sensitivity predicts CV damage in essential hypertension

14 Aug 2022

News & Updates

Filter by Specialty:

Specialty:

ARBs protect kidney function in hypertensive patients

ARBs protect kidney function in hypertensive patients

Subgroup analyses boost masupirdine potential for AD

Subgroup analyses boost masupirdine potential for AD

Mammography screening tied to better breast cancer characteristics, outcomes

Mammography screening tied to better breast cancer characteristics, outcomes

Elderly men with PTSD at risk of Parkinson’s

Elderly men with PTSD at risk of Parkinson’s

Rose Bengal PDAT a promising adjunct therapy for infectious keratitis

Rose Bengal PDAT a promising adjunct therapy for infectious keratitis

Original New Drug Application Approvals by US FDA (01 - 15 August 2022)

Original New Drug Application Approvals by US FDA (01 - 15 August 2022)

Soticlestat shows promise in rare, severe forms of childhood epilepsy

Soticlestat shows promise in rare, severe forms of childhood epilepsy

Laparoscopic pancreaticoduodenectomy a feasible oncological intervention

Laparoscopic pancreaticoduodenectomy a feasible oncological intervention

HCV reinfection highest among people with ongoing injecting drug use

HCV reinfection highest among people with ongoing injecting drug use

Inverse salt sensitivity predicts CV damage in essential hypertension

Inverse salt sensitivity predicts CV damage in essential hypertension